Outlook Therapeutics (OTLK) Total Debt: 2015-2020
Historic Total Debt for Outlook Therapeutics (OTLK) over the last 4 years, with Jun 2020 value amounting to $544,924.
- Outlook Therapeutics' Total Debt fell 91.94% to $544,924 in Q2 2020 from the same period last year, while for Jun 2020 it was $544,924, marking a year-over-year decrease of 91.94%. This contributed to the annual value of $6.7 million for FY2019, which is 3991.29% up from last year.
- Latest data reveals that Outlook Therapeutics reported Total Debt of $544,924 as of Q2 2020, which was up 2,019.58% from $25,709 recorded in Q1 2020.
- Outlook Therapeutics' 5-year Total Debt high stood at $13.3 million for Q3 2017, and its period low was $25,709 during Q1 2020.
- Its 3-year average for Total Debt is $5.7 million, with a median of $6.8 million in 2019.
- As far as peak fluctuations go, Outlook Therapeutics' Total Debt surged by 3,991.29% in 2019, and later tumbled by 99.67% in 2020.
- Over the past 5 years, Outlook Therapeutics' Total Debt (Quarterly) stood at $5.1 million in 2016, then soared by 140.69% to $12.3 million in 2017, then fell by 25.86% to $9.1 million in 2018, then plummeted by 99.58% to $38,011 in 2019, then slumped by 91.94% to $544,924 in 2020.
- Its Total Debt stands at $544,924 for Q2 2020, versus $25,709 for Q1 2020 and $38,011 for Q4 2019.